Androgen Antagonists Concept

subject area of

• A Phase II, Randomized, Multicenter Study Comparing 10 Months versus 4 Months of Degarelix Therapy in Prolonging the Off Treatment Interval in Men with Localized Prostate Cancer Receiving Intermittent Androgen Deprivation Therapy for Biochemical Recurrence following Radical Local Therapy  Academic Article
• Abiraterone acetate for patients with metastatic castration-resistant prostate cancer progressing after chemotherapy: final analysis of a multicentre, open-label, early-access protocol trial  Academic Article
• Adjuvant radiation therapy, androgen deprivation, and docetaxel for high-risk prostate cancer postprostatectomy: Results of NRG Oncology/RTOG study 0621  Academic Article
• Androgen deprivation and thromboembolic events in men with prostate cancer  Academic Article
• Androgen-dependent regulation of medium and long chain fatty acids uptake in prostate cancer  Academic Article
• Androgens induce oxidative stress and radiation resistance in prostate cancer cells though NADPH oxidase  Academic Article
• Assessment methods and management of hypersexuality and paraphilic disorders  Academic Article
• Attenuation of Resting but Not Load-Mediated Protein Synthesis in Prostate Cancer Patients on Androgen Deprivation  Academic Article
• Behavioral and physiological responses of a wild teleost fish to cortisol and androgen manipulation during parental care  Academic Article
• Bone Health and Bone-Targeted Therapies for Nonmetastatic Prostate Cancer  Academic Article
• Bone Health and Bone-Targeted Therapies for Nonmetastatic Prostate Cancer  Academic Article
• Cabazitaxel versus abiraterone or enzalutamide in poor prognosis metastatic castration-resistant prostate cancer: a multicentre, randomised, open-label, phase II trial  Academic Article
• Cancer Treatment–Induced Bone Loss in Breast and Prostate Cancer  Academic Article
• Cardiovascular Morbidity in a Randomized Trial Comparing GnRH Agonist and GnRH Antagonist among Patients with Advanced Prostate Cancer and Preexisting Cardiovascular Disease  Academic Article
• Cardiovascular Risk in Men with Prostate Cancer: Insights from the RADICAL PC Study  Academic Article
• Cardiovascular effects of androgen depletion and replacement therapy  Academic Article
• Cardiovascular risk with androgen deprivation therapy for prostate cancer: Potential mechanisms  Academic Article
• Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.  Academic Article
• Current management of advanced and castration resistant prostate cancer.  Academic Article
• Disease volume and distribution as drivers of treatment decisions in metastatic prostate cancer: From chemohormonal therapy to stereotactic ablative radiotherapy of oligometastases  Academic Article
• Distribution of nitroreductive activity toward nilutamide in rat  Academic Article
• Duration of Androgen Suppression Before Radiotherapy for Localized Prostate Cancer: Radiation Therapy Oncology Group Randomized Clinical Trial 9910  Academic Article
• Editorial Comment  Academic Article
• Effects of a model androgen (methyl testosterone) and a model anti-androgen (cyproterone acetate) on reproductive endocrine endpoints in a short-term adult mummichog (Fundulus heteroclitus) bioassay  Academic Article
• Fire Fetishism, Diagnostic and Clinical Implications: A Review of Two Cases*  Academic Article
• GU radiation oncologists consensus on bone loss from androgen deprivation.  Academic Article
• GnRH antagonist associates with less adiposity and reduced characteristics of metabolic syndrome and atherosclerosis compared with orchiectomy and GnRH agonist in a preclinical mouse model1Contributed equally and share first authorship.  Academic Article
• Imaging, procedural and clinical variables associated with tumor yield on bone biopsy in metastatic castration-resistant prostate cancer  Academic Article
• Impact of sildenafil on marital and sexual adjustment in patients and their wives after radiotherapy and short-term androgen suppression for prostate cancer  Academic Article
• Inter-related in vitro effects of androgens, fatty acids and oxidative stress in prostate cancer: A mechanistic model supporting prevention strategies  Academic Article
• Intermittent Androgen Suppression for Rising PSA Level after Radiotherapy  Academic Article
• Intermittent androgen deprivation therapy for prostate cancer: translating randomized controlled trials into clinical practice.  Academic Article
• Locally advanced prostate cancer: a population-based study of treatment patterns  Academic Article
• Long-term Followup of a Randomized Trial of 0 Versus 3 Months of Neoadjuvant Androgen Ablation Before Radical Prostatectomy  Academic Article
• Metabolism of nilutamide in rat lung  Academic Article
• New-onset psychosis following androgen deprivation therapy for prostate cancer.  Academic Article
• Optimizing Anticancer Therapy in Metastatic Non-Castrate Prostate Cancer: American Society of Clinical Oncology Clinical Practice Guideline  Academic Article
• Osteoporosis Associated with the Treatment of Paraphilias: A Clinical Review of Seven Case Reports  Conference Paper
• Oxidative Stress and Bioindicators of Reproductive Function in Pulp and Paper Mill Effluent Exposed White Sucker  Academic Article
• PREDICTORS OF PATHOLOGICAL STAGE BEFORE NEOADJUVANT ANDROGEN WITHDRAWAL THERAPY AND RADICAL PROSTATECTOMY  Academic Article
• Pharmacologic Treatment of Paraphilias  Academic Article
• Protocols for the Use of Cyproterone, Medroxyprogesterone, and Leuprolide in the Treatment of Paraphilia  Academic Article
• Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer  Academic Article
• Randomized, Double-Blinded, Placebo-Controlled, Trial of Risedronate for the Prevention of Bone Mineral Density Loss in Nonmetastatic Prostate Cancer Patients Receiving Radiation Therapy Plus Androgen Deprivation Therapy  Academic Article
• Randomized, Prospective, Controlled Study Comparing Radical Prostatectomy Alone and Neoadjuvant Androgen Withdrawal in the Treatment of Localized Prostate Cancer  Academic Article
• Reduction of Nilutamide by NO Synthases:  Implications for the Adverse Effects of This Nitroaromatic Antiandrogen Drug  Academic Article
• Sexually aggressive men.  Academic Article
• Synthesis and Structure–Activity Relationships of the First Ferrocenyl-Aryl-Hydantoin Derivatives of the Nonsteroidal Antiandrogen Nilutamide  Academic Article
• The Neurobiology, Neuropharmacology, and Pharmacological Treatment of the Paraphilias and Compulsive Sexual Behaviour  Academic Article
• The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the biological treatment of paraphilias  Academic Article
• The effectiveness and safety of treatments used for polycystic ovarian syndrome management in adolescents: a systematic review and network meta-analysis protocol  Academic Article
• Therapeutic options in advanced prostate cancer: Present and future  Academic Article
• Treatment of advanced cancer of the prostate.  Academic Article
• Uncovering the Metabolic Complications of Androgen Deprivation Therapy in Patients with Prostate Cancer—Where Do We Take it Next?  Academic Article